NSEAnalysts/Institutional Investor Meet/Con. Call Updates2d ago · 18 Aug 2026, 05:13 pm

Analysts/Institutional Investor Meet/Con. Call Updates

India Pesticides Limited · IPL

✦ AI SummaryResults

India Pesticides Limited has informed the Exchange about Transcript of Earning call for Q1 FY27. The company's consolidated revenue from operations was at INR 256 crores compared to INR 282 crores in Q1 FY26. EBITDA for the quarter was at INR 39 crores with an EBITDA margin of 15.4% while PAT was at INR 23 crores.

Analysis Scores

Earnings Impact6/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact7/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

India Pesticides Limited has informed the Exchange about Transcript of Earning call for Q1 FY27

Attachments (1)

📄

IPL_18082026171306_Transcript_of_the_Earnings_Call.pdf

pdf

Download →
View document text
INDIA PESTICIDES LIMITED An ISO 9001:2015, 14001:2015, 45001:2018 and 10002:2018 Company CIN No. L24112 UP1984PLC006894 GSTIN- 09AAACI3591D1ZO IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLLIPLIPL IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPLIPLIPLIPLIPL Water Works Road, Aishbagh, Lucknow – 226004 (INDIA) Tel: +91-522-2653602, 2653603, 2653622, 4041014 Fax: +91-522-2653610 Website: www.indiapesticideslimited.com E-mail: info@indiapesticideslimited.com Date: 18.08.2026 To To The Manager, The Manager, Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, Mumbai-400001 Exchange Plaza, Plot no. C/1, G Block, Scrip Code: 543311 Bandra- Kurla Complex, Mumbai-400051 ISIN: INE0D6701023 Symbol: IPL Dear Sir/ Ma'am, Sub: Transcript of the Earnings Call for the quarter ended 30th June, 2026. Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the transcript of the Analyst/Investors Call held on Thursday, 13th August, 2026 at 12:30 P.M, in respect of the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2026. The transcript of the earnings call is also available on the Company’s website at www.indiapesticideslimited.com Kindly take the above on your record. Thanking you Yours faithfully, For India Pesticides Limited (Narendra Ojha) Company Secretary and Compliance Officer Encl.: As Above IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPL Regd. Office: Swarup Bhawan, 35-A, Civil Lines, Bareilly – 243 001. Uttar Pradesh, India. Phone: 0581-2567476 Manufacturing Unit 1: Plot No: E-17 to E-23 & G-31 to G-35, UPSIDC Industrial Area, Dewa Road, Chinhat, Lucknow, (UP) Manufacturing Unit 2: Plot No: K-2 to K-12 & D-2 to D-4, UPSIDC Industrial Area, Sandila, Hardoi, (UP) “India Pesticides Limited Q1 FY27 Earnings Conference Call” August 13, 2026 MANAGEMENT: MR. D. K. JAIN – CHIEF EXECUTIVE OFFICER MR. S. P. GUPTA – CHIEF FINANCIAL OFFICER MODERATOR: MR. NITIN RAHEJA – DOLAT CAPITAL Page 1 of 12 India Pesticides Limited August 13, 2026 Moderator: Ladies and gentlemen, good day and welcome to the India Pesticides Q1 FY27 Earnings Conference Call hosted by Dolat Capital. As a reminder, all participant lines will be in the listen- only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touchtone phone. Please note that this call is being recorded. I now hand the conference over to Mr. Nitin Raheja from Dolat Capital. Thank you and over to you, sir. Nitin Raheja: Thank you, Shruti. Good afternoon, everyone. On behalf of Dolat Capital, I would like to thank the management of India Pesticides Limited for giving us the opportunity to host their Q1 FY27 earnings conference call. From the management team, we have with us Mr. D.K. Jain, Chief Executive Officer, and Mr. S.P. Gupta, Chief Financial Officer. Without further ado, I would like to hand over the call to the management for their opening remarks, post which we will open the forum for the Q&A session. Thank you and over to you, sir. D. K. Jain: Thank you, Nitin ji. Good afternoon, ladies and gentlemen. I take pleasure in welcoming you all to the Q1 FY27 earnings conference of India Pesticides Limited. I hope you and your family are doing well. I take the pleasure of welcoming you all to this conference and I trust you have reviewed the financial statements and earning presentation uploaded on the exchanges and our website. We commenced FY27 amid a challenging operating environment in the international and domestic agrochemical market. During the quarter, the industry continued to experience subdued demand conditions, particularly in paddy and other crop protection segments. Despite these near- term challenges, IPL remained focused on operational discipline, customer engagement and maintaining efficiency across its manufacturing operations. During FY27 Q1, consolidated revenue from operations was at INR 256 crores compared to INR 282 crores in Q1 FY26. EBITDA for the quarter was at INR39 crores with an EBITDA margin of 15.4% while PAT was at INR 23 crores. The performance during the quarter was impacted by softer domestic demand for the company's key herbicide namely Pretilachlor along with the higher employee and fuel cost. However, the company continued to focus on cost management, improving operational efficiencies and disciplined execution across business segments. From a business perspective, domestic market remains impacted during the quarter due to a slower demand condition, deficient rainfall resulting in nonsowing or slow sowing during this period. Export revenue during FY27 quarter 1 was at INR 89 crores contributing approximately 35% of total revenue. The company continues to strengthen its presence across more than 35 countries and maintains long-standing relationship with global agrochemical companies. Our ability to manufacture complex offpatent technicals supported by strong quality standards and regulatory compliance continues to support our position as a preferred partner for global customers. Page 2 of 12 India Pesticides Limited August 13, 2026 A key milestone during the quarter was the receipt of Technical Equivalence approval from the European Union for one of our fungicide products. This approval represents an important step in our global expansion strategy and strengthens our ability to cater to international markets. It enhances our access to the European market and creates opportunities for expanding our export business over the coming years. This achievement reflects the strength of our R&D capabilities, product development expertise and continued effort, focus on meeting global requirements of regulatory point of view. Our manufacturing capabilities continue to remain an important pillar of our growth strategy. The company currently operates manufacturing facilities at Sandila, Hardoi, Dewa Road and with a combined capacity of 28,300 metric tons of technical and about 10,200 metric tons of formulated products. Development at our Hamirpur facility continues to progress as planned with 2 out of 10 blocks currently operational. The facility provides a clear pathway for future capacity expansion and will support incremental growth opportunities across specialty products. During the quarter, we continued to strengthen our backward integration initiatives and manufacturing capabilities. Our intermediate plant developed using in-house indigenous R&D technology, supports supply chain stability and reduces dependence on imported intermediates. These initiatives are aligned with our focus on developing self-reliant manufacturing capabilities and improving operational efficiency over the long run. Research and development continue to be the key focus area for IPL. Our DSIR approved R&D facilities remain focused on process innovation, development of new molecules and intermediates, improving product yield [Showing first 8,000 characters — download PDF for full document]